Event

Neuropharmacy MasterClass 2 – Module 1

Course Fully booked

15 Oct - 17 Oct 2020

Neuropharm


This Neuropharmacy MasterClass is designed for specialist pharmacists who are already working in neurology and want to enhance their skills in multiple sclerosis (MS), headache disorders, Parkinson’s disease and epilepsy. Module 1 is looking at MS and Parkinson's, whereas module 2 will cover epilepsy and headache disorders.

Before returning for the second module, a service development / review audit should be undertaken back at your workplace, which will be presented back to the cohort at module 2. Learners will also receive mentorship while completing the inter-module project of their choice.

What will it cost?

The course is fully funded. Your fully funded fee covers the costs of the MasterClass and the whole course must be attended in full. A cancellation charge applies, as per terms and conditions.

This virtual MasterClass will be filmed, live streamed and recorded. You will be able to ask your questions during the Q&A live sessions and connect with delegates in our forum.

Module 2: 23-24 April 2021, Sheffield

To complete the course delegates must return for module 2, which will cover epilepsy and headache disorders. → Click here for module 2


Programme

This MasterClass programme has been carefully developed by Joela Mathews and Rachel Dorsey-Campbell, both neurology pharmacists, to equip pharmacists with specialist skills in managing the different aspects of patients with neurology conditions. The course is ideally for pharmacists who are band 7 or above, and assumes a level of knowledge about the pathology of the conditions and their treatment options.

Download now (NPMC2-NPMC2.1-Neuropharmacy-MasterClass-2-Module-1-October-2020-2.pdf)
An innovative training programme for pharmacy professionals

Developed in recognition of the essential role that neuro-pharmacists can play in a good neurology team, this Academy exists for pharmacy professionals who want to develop expertise in neurological conditions.